Abstract
Flavonoids, the most diverse class of plant secondary metabolites, exhibit high affinity toward the purified cytosolic NBD2(C-terminal nucleotide-binding domain) of P-glycoprotein (P-gp). To explore the affinity of flavonoids for P-gp, quantitative structure-activity relationships (QSARs) models were developed using back-propagation artificial neural networks (BPANN) and multiple linear regression (MLR). Molecular descriptors were calculated using PaDELDescriptor, and the number of descriptors was then reduced using a genetic algorithm (GA) and stepwise regression. The MLR (R2=0.855, q2=0.8138, Rext 2=0.6916), 14-3-1 BPANN (R2=0.8514, q2=0.7695, Rext 2=0.8142), 14-4-1 BPANN (R2=0.9199, q2=0.7733, Rext 2 =0.8731), and 14-5-1 BPANN (R2=0.8660, q2=0.7432, Rext 2 =0.8292) models all showed good robustness. While BPANN models exceeded significantly MLR in predictable performance for their flexible characters, could be used to predict the affinity of flavonoids for P-gp and applied in further drug screening.
Keywords: Back-propagation artificial neural networks, flavonoids, genetic algorithm, P-glycoprotein.
Combinatorial Chemistry & High Throughput Screening
Title:A Genetic Algorithm- Back Propagation Artificial Neural Network Model to Quantify the Affinity of Flavonoids Toward P-Glycoprotein
Volume: 17 Issue: 2
Author(s): Jibin Shen, Ying Cui, Jun Gu, Yaxiao Li and Lingzhi Li
Affiliation:
Keywords: Back-propagation artificial neural networks, flavonoids, genetic algorithm, P-glycoprotein.
Abstract: Flavonoids, the most diverse class of plant secondary metabolites, exhibit high affinity toward the purified cytosolic NBD2(C-terminal nucleotide-binding domain) of P-glycoprotein (P-gp). To explore the affinity of flavonoids for P-gp, quantitative structure-activity relationships (QSARs) models were developed using back-propagation artificial neural networks (BPANN) and multiple linear regression (MLR). Molecular descriptors were calculated using PaDELDescriptor, and the number of descriptors was then reduced using a genetic algorithm (GA) and stepwise regression. The MLR (R2=0.855, q2=0.8138, Rext 2=0.6916), 14-3-1 BPANN (R2=0.8514, q2=0.7695, Rext 2=0.8142), 14-4-1 BPANN (R2=0.9199, q2=0.7733, Rext 2 =0.8731), and 14-5-1 BPANN (R2=0.8660, q2=0.7432, Rext 2 =0.8292) models all showed good robustness. While BPANN models exceeded significantly MLR in predictable performance for their flexible characters, could be used to predict the affinity of flavonoids for P-gp and applied in further drug screening.
Export Options
About this article
Cite this article as:
Shen Jibin, Cui Ying, Gu Jun, Li Yaxiao and Li Lingzhi, A Genetic Algorithm- Back Propagation Artificial Neural Network Model to Quantify the Affinity of Flavonoids Toward P-Glycoprotein, Combinatorial Chemistry & High Throughput Screening 2014; 17 (2) . https://dx.doi.org/10.2174/1386207311301010002
DOI https://dx.doi.org/10.2174/1386207311301010002 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy
Current Molecular Medicine Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Current Cancer Drug Targets Biotransformation of Endocrine Disrupting Compounds by Selected Phase I and Phase II Enzymes – Formation of Estrogenic and Chemically Reactive Metabolites by Cytochromes P450 and Sulfotransferases
Current Medicinal Chemistry Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry Non-Analgesic Effects of Opioids: Opioids and the Endocrine System
Current Pharmaceutical Design Can't Always Get What you Want? Try an Indirect Route you Just Might Get What you Need: A Study on Access to Genetic Data by Canadian Life Insurers
Current Pharmacogenomics and Personalized Medicine Relevance of the Salvage Pathway to N-Hexanoylsphingosine Metabolic Downregulation in Human Neurotumor Cells: Implications for Apoptosis
Drug Metabolism Letters Discovery of Small Molecules that Target Autophagy for Cancer Treatment
Current Medicinal Chemistry Opioid Analgesics and P-Glycoprotein Efflux Transporters: A Potential Systems-Level Contribution to Analgesic Tolerance
Current Topics in Medicinal Chemistry A Review of Ruthenium Complexes Activities on Breast Cancer Cells
Mini-Reviews in Medicinal Chemistry Ultrasound Assisted-synthesis and Biological Evaluation of Piperazinylprop- 1-en-2-yloxy-2H-chromen-2-ones as Cytotoxic Agents
Letters in Drug Design & Discovery Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Current Topics in Medicinal Chemistry Nucleoside Transporter Proteins
Current Vascular Pharmacology Natural Sesquiterpenoids as Cytotoxic Anticancer Agents
Mini-Reviews in Medicinal Chemistry Monoclonal Antibody-based Genetic Immunotherapy
Current Gene Therapy Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions
Reviews on Recent Clinical Trials Recent Progress in Biomedical Applications of Magnetic Nanoparticles
Recent Patents on Nanotechnology Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer
Recent Patents on Anti-Cancer Drug Discovery Osteoimmunology and Beyond
Current Medicinal Chemistry Biomedical Applications of Natural Polymers for Drug Delivery
Current Organic Chemistry